Nautilus will host a conference call to discuss the first quarter 2025 financial results, business developments and outlook before market open on Tuesday, April 29, 2025, at 5:30 AM Pacific Time / ...

Few of Elon Musk’s companies would have been possible without the energy density and stability of lithium-ion batteries. In ...

VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment ...

The company, which has been targeted by Washington, saw US revenue jump 28 per cent in the first quarter, compared with 21 ...

Enhancing wheat plants' sugar signaling ability could deliver increased yields of up to 12%, according to researchers from ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

HudsonAlpha Institute for Biotechnology is looking for participants to take part in a new pilot study to see how genetics and ...

Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq ...

Champions Oncology, Inc.’s CSBR share price has dipped by 5.57%, which has investors questioning if this is right time to buy ...

Novel glycan-directed ADC shows preclinical activity in gastric cancer and potential to address underserved patient population ...